BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
See today's BioWorld MedTech
Home
» FDA approves new MRI uses for Cyberonics' VNS patients
To read the full story,
subscribe
or
sign in
.
FDA approves new MRI uses for Cyberonics' VNS patients
Nov. 2, 2011
By
Amanda Pedersen
No Comments
Cyberonics (Houston) said the FDA has approved a significant expansion of options for MRI use by patients who have the company's VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.
BioWorld MedTech